Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.782
+0.062 (3.59%)
Jun 26, 2026, 12:51 PM EDT - Market open
Imunon Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
7.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | 500.00K | - | - |
| Dec 31, 2019 | 500.00K | - | - |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | 500.00K | - | - |
| Dec 31, 2016 | 500.00K | - | - |
| Dec 31, 2015 | 500.00K | - | - |
| Dec 31, 2014 | 500.00K | - | - |
| Dec 31, 2013 | 500.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 2.00M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | 2.50M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HCW Biologics | 6.59M |
| Bolt Biotherapeutics | 6.50M |
| Immuron | 4.99M |
| Xenetic Biosciences | 3.19M |
| Can-Fite BioPharma | 405.00K |
| AIM ImmunoTech | 94.00K |
| Creative Medical Technology Holdings | 3.00K |
IMNN News
- 1 day ago - Imunon Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 1 day ago - Imunon Slides: Life Sciences Virtual Investor Forum - Filings
- 3 days ago - Imunon announces IDMC recommendation for continuation of OVATION 3 trial - TheFly
- 3 days ago - IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification - GlobeNewsWire
- 3 days ago - IMUNON to Present at the Life Sciences Investor Forum on June 25th - GlobeNewsWire
- 10 days ago - Imunon Transcript: AGM 2026 - Transcripts
- 22 days ago - IMUNON Announces Up to $10 Million Cash Financing - GlobeNewsWire
- 6 weeks ago - Imunon reports Q1 EPS (84c), consensus ($1.28) - TheFly